A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome
Clinical trial NCT05902598 · COMPLETED
Trial details
- NCT number
- NCT05902598
- Sponsor
- Visirna Therapeutics HK Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2024-11-26
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.